Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ALXN

Alexion Pharmaceuticals (ALXN) Stock Price, News & Analysis

Alexion Pharmaceuticals logo

About Alexion Pharmaceuticals Stock (NASDAQ:ALXN)

Advanced Chart

Key Stats

Today's Range
$182.50
$182.50
50-Day Range
$179.45
$186.61
52-Week Range
$99.91
$187.45
Volume
10 shs
Average Volume
3.31 million shs
Market Capitalization
$40.34 billion
P/E Ratio
59.64
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ALXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alexion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ALXN Stock News Headlines

Alexion Stock Price History
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Alexion’s ravulizumab granted FDA orphan designation
Monopar's Incredible Journey From $5 To $50 In Less Than 5 Months
AstraZeneca's Alexion Inks Deal With Pan-Canadian Pharmaceutical Alliance
See More Headlines

ALXN Stock Analysis - Frequently Asked Questions

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) issued its quarterly earnings data on Thursday, April, 29th. The biopharmaceutical company reported $3.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.16 by $0.36. The firm's revenue was up 13.3% compared to the same quarter last year.

The following companies are subsidiaries of Alexion Pharmaceuticals: Portola Pharmaceuticals Inc., Achillion Pharmaceuticals, Syntimmune, Wilson Therapeutics, Synageva BioPharma Corp., Enobia Pharma Corp., Taligen Therapeutics Inc., and others.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alexion Pharmaceuticals investors own include Meta Platforms (META), NVIDIA (NVDA), Bristol Myers Squibb (BMY), Tesla (TSLA), Netflix (NFLX), Gilead Sciences (GILD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
4/29/2021
Today
8/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ALXN
CIK
899866
Fax
N/A
Employees
3,837
Year Founded
1992

Profitability

EPS (Trailing Twelve Months)
$11.60
Trailing P/E Ratio
59.64
Forward P/E Ratio
13.95
P/E Growth
0.93
Net Income
$603.40 million
Net Margins
10.89%
Pretax Margin
N/A
Return on Equity
23.43%
Return on Assets
15.06%

Debt

Debt-to-Equity Ratio
0.19
Current Ratio
4.52
Quick Ratio
3.96

Sales & Book Value

Annual Sales
$6.07 billion
Price / Sales
6.65
Cash Flow
$22.81 per share
Price / Cash Flow
8.00
Book Value
$53.24 per share
Price / Book
3.43

Miscellaneous

Outstanding Shares
221,019,000
Free Float
N/A
Market Cap
$40.34 billion
Optionable
Optionable
Beta
1.25

Social Links

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:ALXN) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners